SCHEMBL17087678

SCHEMBL17087678

CO[C@@H]1OC(CO)[C@H](O)C(O[C@@H]2OC(C(=O)O)[C@@H](O)C(O)C2O)C1O

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 7/20 0.55
▸ FGF1 P05230 1/20 0.44
▸ FGF2 P09038 1/20 0.44
▸ VEGFA P15692 1/20 0.44
▸ HPSE Q9Y251 1/20 0.44
▸ LGALS3 P17931 2/20 0.43
▸ LGALS9 O00182 1/20 0.43
▸ LGALS1 P09382 1/20 0.43
▸ LGALS7; LGALS7B P47929 1/20 0.43
▸ IGF2R P11717 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CD209 Q9NNX6 1/20 0.41
▸ STAT3 P40763 2/20 0.41
▸ SELE P16581 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10014356 0.95 LGALS8 (0.52) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL10014359 0.90 IGF2R (0.50) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL18476174 0.87 LGALS8 (0.50) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL29632945 0.87 SELE (0.50) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL13867741 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL13559835 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL14255515 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL13560177 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL13559836 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE
SCHEMBL13560166 0.87 LGALS3 (0.47) LGALS8FGF1FGF2VEGFAHPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015136027-A1 CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN UNIVERSITAET BASEL (CH) 2015-09-17 — — WO disclosed
Send feedback